Abstract
The ability to silence gene expression is an invaluable tool for elucidating the importance of intracellular signaling proteins which contribute to the effector functions of mast cells and basophils. However, primary mast cells and their terminally differentiated blood counterpart, namely basophils, pose a difficult challenge for gene silencing approaches given not only their state of maturation and difficulty to transfect, but also because their functions are readily altered by cell-handling conditions. Here, we describe a method using lipofection which has been successfully employed to silence gene expression using siRNA in human LAD2 mast cells as well as primary human basophils.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Norata GD, Tibolla G, Catapano AL (2013) Gene silencing approaches for the management of dyslipidaemia. Trends Pharmacol Sci 34:198–205
Macrae I, Zhou K, Li F, Repic A, Brooks A, Cande W, Adams P, Doudna J (2006) Structural basis for double-stranded RNA processing by dicer. Science 311:195–198
Sumbayev VV, Nicholas SA, Streatfield CL, Gibbs BF (2009) Involvement of hypoxia-Inducible Factor-1 in IgE-mediated primary human basophil responses. Eur J Immunol 39:3511–3519
Sumbayev VV, Yasinska IM, Oniku AE, Streatfield CL, Gibbs BF (2012) Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. PLoS One 7:e34259
Wang Z, Rao DD, Senzer N, Nemunaitis J (2011) RNA interference and cancer therapy. Pharm Res 28:2983–2995
Imai E, Isaka Y (2002) Gene electrotransfer: potential for gene therapy of renal diseases. Kidney Int 61:S37–S41
Vilarino N, MacGlashan D Jr (2005) Transient transfection of human peripheral blood basophils. J Immunol Methods 296:11–18
Burke B (2003) Macrophages as novel cellular vehicles for gene therapy. Expert Opin Biol Ther 3:919–924
Sumbayev VV, Yasinska IM, Gibbs BF (2013) Biomedical applications of gold nanoparticles. In: Said A, Tang CH, Oprisan S (eds) Recent advances in circuits, communications and signal processing, WSEAS Press, Athens, pp 342–348
Nicholas SA, Sumbayev VV (2009) The involvement of hypoxia-inducible factor 1 alpha in Toll-like receptor 7/8-mediated inflammatory response. Cell Res 19:973–983
Shatrov VA, Sumbayev VV, Zhou J, Bruene B (2003) Oxidized low density lipoprotein triggers HIF-1alpha protein via redox-dependent mechanism. Blood 101:4847–4849
Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP et al (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27:677–682
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Sumbayev, V.V., Gibbs, B.F. (2014). Gene Silencing Approaches in Mast Cells and Primary Human Basophils. In: Gibbs, B., Falcone, F. (eds) Basophils and Mast Cells. Methods in Molecular Biology, vol 1192. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1173-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1173-8_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1172-1
Online ISBN: 978-1-4939-1173-8
eBook Packages: Springer Protocols